Sex Differences in Neuropeptide Y Serum, But Not in Fat Intake and Body Mass Index

Universitas Sumatera Utara

Status: Completed

Conditions: Nutrient Deficiency

Treatments: Diagnostic Test: Neuropeptide Y examination

Study type: Interventional

Funder types: Other

Identifiers

NCT04650308

USumateraUtara 2

Details and patient eligibility

About

One's appetite has a role in controlling food intake and maintaining energy balance, but its effect on body metabolism related to obesity is still questionable. The purpose of this study was to determine the levels of neuropeptide Y in healthy people and to see differences in gender and anthropometric parameters. The hypothesis of this study was that there would be differences in neuropeptide Y levels in groups with gender and anthropometric parameter differences.

Full description

One's appetite has a role in controlling food intake and maintaining energy balance, but its effect on body metabolism related to obesity is still questionable. The purpose of this study was to determine the levels of neuropeptide Y in healthy people and to see differences in gender and anthropometric parameters. The hypothesis of this study was that there would be differences in neuropeptide Y levels in groups with gender and anthropometric parameter differences. This study was a cross-sectional study involving 62 study subjects, male and female, who did not have chronic diseases or metabolic disorders. This research was conducted from April to September 2020. The parameters examined in this study were neuropeptide Y levels and anthropometric parameters. The statistical analysis performed was the Mann-Whitney test to see the differences between groups. The mean age of the research subjects was 40.48 ± 10.85 years, with the same ethnic distribution. The distribution of men and women was more women than men. Based on anthropometric examination, it was found that obesity nutritional status was more common in the female group than in the male group; however, serum neuropeptide Y levels were found to be significantly different between male and female groups (male group was higher).

Enrollment: 62 patients

Sex: All

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy groups for Neuropeptide Y Serum diagnosis

Exclusion criteria

• Non-healthy groups for Neuropeptide Y Serum diagnosis

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

62 participants in 2 patient groups

Healthy group

Active Comparator group

Description:

healthy men and women aged 20-60 years old.

Treatment:

Diagnostic Test: Neuropeptide Y examination

Non-healthy group

Active Comparator group

Description:

pregnant women, nursing mothers, impaired kidney and liver function, chronic disease, or other metabolic disorders.

Treatment:

Diagnostic Test: Neuropeptide Y examination